Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Prevention Research
Cancer Prevention Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Article

Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome

Karen H. Lu, David S. Loose, Melinda S. Yates, Graciela M. Nogueras-Gonzalez, Mark F. Munsell, Lee-may Chen, Henry Lynch, Terri Cornelison, Stephanie Boyd-Rogers, Mary Rubin, Molly S. Daniels, Peggy Conrad, Andrea Milbourne, David M. Gershenson and Russell R. Broaddus
Karen H. Lu
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David S. Loose
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melinda S. Yates
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graciela M. Nogueras-Gonzalez
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark F. Munsell
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lee-may Chen
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Lynch
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terri Cornelison
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Boyd-Rogers
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Rubin
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Molly S. Daniels
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peggy Conrad
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Milbourne
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Gershenson
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russell R. Broaddus
Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1940-6207.CAPR-13-0020 Published August 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: May 2013 to January 2021

AbstractFull-text HTMLPDF
Total449724631531

Cited By

Article Information

Volume 6, Issue 8, pp. 774-781

DOI 
https://doi.org/10.1158/1940-6207.CAPR-13-0020
PubMed 
23639481

Published By 
American Association for Cancer Research
Print ISSN 
1940-6207
Online ISSN 
1940-6215
History 
  • Received January 16, 2013
  • Revision received March 22, 2013
  • Accepted April 16, 2013
  • Published first May 2, 2013.

Article Versions

  • Previous version (May 2, 2013 - 07:02).
  • Previous version (July 25, 2013 - 06:40).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2013 American Association for Cancer Research.

Author Information

  1. Karen H. Lu1,
  2. David S. Loose5,
  3. Melinda S. Yates1,
  4. Graciela M. Nogueras-Gonzalez2,
  5. Mark F. Munsell2,
  6. Lee-may Chen6,
  7. Henry Lynch8,
  8. Terri Cornelison9,
  9. Stephanie Boyd-Rogers1,
  10. Mary Rubin6,
  11. Molly S. Daniels1,3,
  12. Peggy Conrad7,
  13. Andrea Milbourne1,
  14. David M. Gershenson1, and
  15. Russell R. Broaddus4
  1. Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Biostatistics, 3Clinical Cancer Genetics Program, and 4Pathology, The University of Texas MD Anderson Cancer Center; 5Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas; Departments of 6Gynecologic Oncology and 7Medicine, The University of California San Francisco, San Francisco, California; 8Department of Preventative Medicine, Creighton University, Omaha, Nebraska; and 9Department of Gynecologic Oncology, Johns Hopkins University, Baltimore, Maryland
  1. Corresponding Author:
    Karen H. Lu, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Hermann Pressler Dr., Unit 1362, Houston, TX 77030. Phone: 713-745-8902; Fax: 713-792-7586; E-mail: khlu{at}mdanderson.org
View Full Text
PreviousNext
Back to top
Cancer Prevention Research: 6 (8)
August 2013
Volume 6, Issue 8
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Prevention Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome
(Your Name) has forwarded a page to you from Cancer Prevention Research
(Your Name) thought you would be interested in this article in Cancer Prevention Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome
Karen H. Lu, David S. Loose, Melinda S. Yates, Graciela M. Nogueras-Gonzalez, Mark F. Munsell, Lee-may Chen, Henry Lynch, Terri Cornelison, Stephanie Boyd-Rogers, Mary Rubin, Molly S. Daniels, Peggy Conrad, Andrea Milbourne, David M. Gershenson and Russell R. Broaddus
Cancer Prev Res August 1 2013 (6) (8) 774-781; DOI: 10.1158/1940-6207.CAPR-13-0020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome
Karen H. Lu, David S. Loose, Melinda S. Yates, Graciela M. Nogueras-Gonzalez, Mark F. Munsell, Lee-may Chen, Henry Lynch, Terri Cornelison, Stephanie Boyd-Rogers, Mary Rubin, Molly S. Daniels, Peggy Conrad, Andrea Milbourne, David M. Gershenson and Russell R. Broaddus
Cancer Prev Res August 1 2013 (6) (8) 774-781; DOI: 10.1158/1940-6207.CAPR-13-0020
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Breast Cancer Genetic Risk and Endocrine Therapy Acceptance
  • Obesity and Telomere Length in Prostate Stromal Cells
  • Regulatory T Cells and Melanocytic Nevi
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Prevention Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Prevention Research
eISSN: 1940-6215
ISSN: 1940-6207

Advertisement